<DOC>
	<DOCNO>NCT03072004</DOCNO>
	<brief_summary>We go investigate leprosy patient neuropathy . This problem lead change nerve function lead disability . We investigate protocol LLLT improve pain , inflammation , prevent disability . We test two group , divide control LLLT treat patient . In group perform quantitative measurement follow parameter protocol application : electroneuromyography muscle strength measurement , evaluation activity limitation risk awareness , evaluation tactile sensitivity evaluation temperature hand foot . Averages parameter compare treatment ( 12 application session ) . We believe LLLT become important alternative treatment improve conduction velocity , tactile sensitivity , temperatures hand foot , muscle strength pain , prevent nerve damage disability</brief_summary>
	<brief_title>Low Level Laser Therapy Effects Peripheral Nerves Patient With Leprosy .</brief_title>
	<detailed_description>Leprosy infectious disease cause Mycobacterium leprae , obligate intracellular bacillus capacity invade cell peripheral nervous system ( Nations et al. , 1998 ) . This disease present polymorphic clinical feature , destruction peripheral nerve relevant , result irreversible disability great social psychological impact ( Martins et al. , 2008 ) . Among 250,000 new case leprosy detect worldwide every year , 12 % 55 % demonstrate diagnosis sensory , motor autonomic neuropathy ( Saunderson et al. , 2000 ) . The destruction nerve fiber patient leprosy establish presence inflammatory process development autoimmunity cytotoxicity ( Birdi et al. , 1996 ) , include nerve growth factor ( Facer et al. , 1998 ) , glia cell ' adhesion molecule , interferon-gamma , Transforming Growth Factor - Beta ( Goulart et al. , 1996 ; Goulart et al. , 2000 ) , Tumor Necroses Factor-alpha ( Singh , 1998 ) interleukin ( IL-6 , IL-8 , IL-12 IL-10 ) ( Mendonça et al. , 2008 ) . Low Level Laser Therapy ( LLLT ) demonstrate promising treatment neural rehabilitation . Some study , demonstrate LLLT present positive result improve nerve conduction velocity . The literature provide evidence effectiveness LLLT treatment neural rehabilitation , may promise tool leprosy neuropathy rehabilitation . LLLT provide improvement clinical electrophysiological parameter human ulnar neuropathy modality show satisfying short-term effectiveness treatment pathology ( Ozkan et al. , 2014 ) . Other study show LLLT application diabetic polyneuropathy present positive result improve nerve conduction velocity ( Khamseh et al. , 2011 ) . Such neuropathy associate significant physical disability , generate high social-economic cost , important challenge clinical intervention . Currently , leprosy neuropathy treat standard protocol , use either corticoid treatment regimen and/or surgical intervention nerve decompression . Therefore , LLLT may novel auxiliary therapeutic resource leprosy order improve patient ' nerve conduction velocity , diminish pain , minimize physical disability , probably reduce usage period maximum dose corticoid , number surgical procedure future . Furthermore , therapeutic approach also non-invasive treatment relatively low cost . Despite absence study LLLT effect affect nerve patient leprosy , study show positive effect neuropathy , : improvement clinical electrophysiological parameter , reduction pain , improvement inflammation nerve entrapment neuropathy , well promotion nerve regeneration . Considering LLLT approach may promote analgesic effect ( Chen et al. , 2014 ; Ozkan et al. , 2014 ) , improve clinical electrophysiological parameter ( Ozkan et al. , 2014 ; Khamseh et al. , 2011 ) , induce anti-inflammatory effect nerve repair ( Chen et al. , 2014 ; Lazovic et al. , 2014 ; Alcântara et al. , 2013 ; Hsieh et al. , 2012 ) , reduce degeneration myelin sheat increase conduction velocity ( Khamseh et al. , 2011 ) neuropathologies , believe LLLT may also promote favourable effect leprosy neuropathy . This work aim evaluate effect application LLLT peripheral nerve leprosy patient . This project approve N. 989.148/2015 Research Ethics Committee Federal University Uberlandia . A randomized , double-blind , placebo-controlled clinical trial conduct January 2017 December 2019 . The patient recruit National Reference Centre Sanitary Dermatology Leprosy ( CREDESH ) , Federal University Uberlandia ( UFU ) , State Minas Gerais , Brazil inform study procedure sign inform consent form . CREDESH public health care facility endemic region routine prevention , include intradermal Bacilo Calmette-Guérin ( BCG ) vaccination , Household Contacts ( HHCs ) monitoring , early case detection treatment available supervision , multidisciplinary team . Adult patient ( n=92 ) age 18-60 year old diagnose presence focal demyelinate neuropathy compression site ulnar common peroneal nerve . The patient select household contact group become ill follow 5 7 year epidemiological surveillance program CREDESH/UFU . Clinical dermato-neurological examination , serology anti-PGL-1 perform annually . When participant present one positive result follow-up , undergo six slit-skin smear sample bacilloscopy quantitative PCR ( qPCR ) M. leprae DNA M. leprae-specific repetitive element ( RLEP3 ) detection ( lobes right leave ear ; right leave elbow right leave knee ) . Then , patient forward dermato-neurological examination , sensitivity muscle force evaluation ( hand , foot eye ) , incapacity degree evaluation , electroneuromyography examination upper low limb . All patient treat multidrug therapy ( MDT ) , accord operational classification ( Paucibacillary - PB Multibacillary - MB ) Ridley Jopling classification ( tuberculoid and/or borderline tuberculoid ( TT ) , borderline-borderline ( BB ) , borderline lepromatous ( BL ) lepromatous ( LL ) ) . The patient randomize divide two group : 1 . Control : patient receive application `` sham LLLT '' . The laser turn , procedure LLLT group ) ; 2 . LLLT : patient receive treatment LLLT 12 session alternate day 4 week nerve : 1. ulnar nerve : laser probe apply around ulnar nerve elbow region , especially region cubital tunnel total 5 point ( 3 point two point medial epicondyle . The distance application point 1cm . 2. common peroneal nerve : apply LLLT 2 point 3 point surround fibular head . The distance application point 1cm . The LLLT apply use diode laser device parameter : 830 nanometer ( nm ) , 100 milliwatt ( mW ) , 8 Joules ( J ) , 3mW/cm2 . Laser probe apply directly perpendicularly skin contact , time irradiation 80 second per point treatment apply three time week 12 session .</detailed_description>
	<mesh_term>Leprosy</mesh_term>
	<criteria>Inclusion criterion : leprosy patient ; patient show sign focal demyelinate neuropathy compression site ulnar common peroneal nerve ENM ; patient borderline tuberculoid ( BT ) , borderlineborderline ( BB ) , borderline lepromatous ( BL ) lepromatous ( LL ) leprosy form ; patient multidrug therapy ( MDT ) ; ( ) patient live Uberlândia ( Minas Gerais/Brazil ) . Exclusion criterion : patient diagnose form peripheral neuropathy , diagnose diabetes arterial hypertension ; patient physically disabled ; patient cognitive impairment ; refuse sign consent form .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Leprosy</keyword>
	<keyword>Neuropathy</keyword>
	<keyword>LLLT</keyword>
</DOC>